A citation-based method for searching scientific literature

Susumu Ogawa, Kazuhiro Nako, Masashi Okamura, Takuya Sakamoto, Sadayoshi Ito. J Diabetes Investig 2015
Times Cited: 8







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
37


Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
25


Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2015
25


Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Marcus Lind, Irl B Hirsch, Jaakko Tuomilehto, Sofia Dahlqvist, Bo Ahrén, Ole Torffvit, Stig Attvall, Magnus Ekelund, Karin Filipsson, Bengt-Olov Tengmark,[...]. BMJ 2015
52
25

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Katherine Esposito, Dario Giugliano, Francesco Nappo, Raffaele Marfella. Circulation 2004
322
12

Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Chien-Ming Lin, Hui-Ling Huang, Fang-Ying Chu, Hueng-Chuen Fan, Hung-An Chen, Der-Ming Chu, Li-Wei Wu, Chung-Ching Wang, Wei-Liang Chen, Shih-Hua Lin,[...]. PLoS One 2015
23
12

Targets for glycemic control.
S Ali Imran, Rémi Rabasa-Lhoret, Stuart Ross. Can J Diabetes 2013
55
12


A recombinant slow-release PACAP-derived peptide alleviates diabetes by promoting both insulin secretion and actions.
Yi Ma, Shixiong Fang, Shaojun Zhao, Xiaoli Wang, Dongbo Wang, Min Ma, Tianjie Luo, An Hong. Biomaterials 2015
7
14


Postprandial hyperglycemia and glycemic variability: should we care?
Eberhard Standl, Oliver Schnell, Antonio Ceriello. Diabetes Care 2011
120
12

Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base.
Richard D Feinman, Wendy K Pogozelski, Arne Astrup, Richard K Bernstein, Eugene J Fine, Eric C Westman, Anthony Accurso, Lynda Frassetto, Barbara A Gower, Samy I McFarlane,[...]. Nutrition 2015
299
12

Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
Ajmer Singh Grewal, Bhupinder Singh Sekhon, Viney Lather. Mini Rev Med Chem 2014
29
12

Effect of nateglinide on the incidence of diabetes and cardiovascular events.
Rury R Holman, Steven M Haffner, John J McMurray, M Angelyn Bethel, Björn Holzhauer, Tsushung A Hua, Yuri Belenkov, Mitradev Boolell, John B Buse, Brendan M Buckley,[...]. N Engl J Med 2010
303
12

Inhaled insulin: a breath of fresh air? A review of inhaled insulin.
Tricia Santos Cavaiola, Steven Edelman. Clin Ther 2014
58
12

Insulin as a physiological modulator of glucagon secretion.
Pritpal Bansal, Qinghua Wang. Am J Physiol Endocrinol Metab 2008
78
12

Role of hyperglycemia in nitrotyrosine postprandial generation.
Antonio Ceriello, Lisa Quagliaro, Barbara Catone, Roberta Pascon, Marta Piazzola, Bruno Bais, Giampiero Marra, Laura Tonutti, Claudio Taboga, Enrico Motz. Diabetes Care 2002
175
12

The rationale for combining GLP-1 receptor agonists with basal insulin.
Neale D Cohen, Ralph Audehm, Elaine Pretorius, Joey Kaye, Leon H Chapman, Stephen Colagiuri. Med J Aust 2013
13
12


The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart.
A Ceriello, A Cavarape, L Martinelli, R Da Ros, G Marra, L Quagliaro, L Piconi, R Assaloni, E Motz. Diabet Med 2004
83
12

Clinical application of glucagon-like Peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus.
Young Min Cho, Rhonda D Wideman, Timothy J Kieffer. Endocrinol Metab (Seoul) 2013
32
12


Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial.
Juris J Meier, Julio Rosenstock, Agnès Hincelin-Méry, Christine Roy-Duval, Astrid Delfolie, Hans-Veit Coester, Bjoern A Menge, Thomas Forst, Christoph Kapitza. Diabetes Care 2015
160
12

"Mild dysglycemia" in type 2 diabetes: to be neglected or not?
Louis Monnier, Claude Colette, Sylvie Dejager, David R Owens. J Diabetes Complications 2015
9
12


Therapeutic potential of VIP vs PACAP in diabetes.
Ahter D Sanlioglu, Bahri Karacay, Mustafa Kemal Balci, Thomas S Griffith, Salih Sanlioglu. J Mol Endocrinol 2012
29
12


Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.
A M Abbatecola, M R Rizzo, M Barbieri, R Grella, A Arciello, M T Laieta, R Acampora, N Passariello, F Cacciapuoti, G Paolisso. Neurology 2006
98
12

Regulation of hepatic glucose uptake and storage in vivo.
Mary Courtney Moore, Katie C Coate, Jason J Winnick, Zhibo An, Alan D Cherrington. Adv Nutr 2012
161
12

Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes.
Olubukola Ajala, Patrick English, Jonathan Pinkney. Am J Clin Nutr 2013
355
12


Incretin-based therapies: where will we be 50 years from now?
Juris J Meier, Michael A Nauck. Diabetologia 2015
30
12

Association between Visit-to-Visit Glucose Variability and Cognitive Function in Aged Type 2 Diabetic Patients: A Cross-Sectional Study.
Chulho Kim, Jong-Hee Sohn, Min Uk Jang, Sung-Hun Kim, Moon-Gi Choi, Ohk-Hyun Ryu, Sungwha Lee, Hui-Chul Choi. PLoS One 2015
21
12

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.
Franco Cavalot, Andrea Pagliarino, Manuela Valle, Leonardo Di Martino, Katia Bonomo, Paola Massucco, Giovanni Anfossi, Mariella Trovati. Diabetes Care 2011
188
12



Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.
James B Meigs, David M Nathan, Ralph B D'Agostino, Peter W F Wilson. Diabetes Care 2002
388
12

Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications.
Marcos Antonio Tambascia, Domingos Augusto Cherino Malerbi, Freddy Goldberg Eliaschewitz. Einstein (Sao Paulo) 2014
5
20

In vivo performance and biocompatibility of a subcutaneous implant for real-time glucose-responsive insulin delivery.
Michael K L Chu, Claudia R Gordijo, Jason Li, Azhar Z Abbasi, Adria Giacca, Oliver Plettenburg, Xiao Yu Wu. Diabetes Technol Ther 2015
10
12


Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance.
Markolf Hanefeld, Jean Louis Chiasson, Carsta Koehler, Elena Henkel, Frank Schaper, Theodora Temelkova-Kurktschiev. Stroke 2004
199
12

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.
Yehuda Handelsman, Zachary T Bloomgarden, George Grunberger, Guillermo Umpierrez, Robert S Zimmerman, Timothy S Bailey, Lawrence Blonde, George A Bray, A Jay Cohen, Samuel Dagogo-Jack,[...]. Endocr Pract 2015
328
12


Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
Itamar Raz, Peter W F Wilson, Krzysztof Strojek, Irina Kowalska, Velimir Bozikov, Anselm K Gitt, György Jermendy, Barbara N Campaigne, Lisa Kerr, Zvonko Milicevic,[...]. Diabetes Care 2009
230
12

Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes-2015 Interim Update.
William Harper, Maureen Clement, Ronald Goldenberg, Amir Hanna, Andrea Main, Ravi Retnakaran, Diana Sherifali, Vincent Woo, Jean-François Yale, Alice Y Y Cheng. Can J Diabetes 2015
27
12

Molecular mechanisms of diabetic vascular complications.
Munehiro Kitada, Zhaoyun Zhang, Akira Mima, George L King. J Diabetes Investig 2010
83
12

Glycated hemoglobin measurement and prediction of cardiovascular disease.
Emanuele Di Angelantonio, Pei Gao, Hassan Khan, Adam S Butterworth, David Wormser, Stephen Kaptoge, Sreenivasa Rao Kondapally Seshasai, Alex Thompson, Nadeem Sarwar, Peter Willeit,[...]. JAMA 2014
123
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.